Global High-Priority Regulatory Events — July 24, 2026

24-07-2026

Birla Cotsyn (India) Ltd issued a clarification to shareholders and investors regarding the trading status of its equity shares, which are currently categorized by BSE Limited as 'Trading Restricted – On account of IRP as per IBC / Recommencement post IBC – IBC Stage-1'. The company explains that this classification is a routine regulatory surveillance mechanism following the successful implementation of a Resolution Plan approved by the NCLT Mumbai Bench on January 9, 2025, and does not indicate any adverse financial or operational issues. The filing contains no financial data or performance metrics.

• · The NCLT Mumbai Bench approved the Resolution Plan on 09th January, 2025.
• · Trading recommenced after BSE approval following successful implementation of the Resolution Plan.
• · The current trading classification is part of BSE's surveillance framework for companies post-IBC.

24-07-2026

Apar Industries Limited reported consolidated revenue from operations of ₹6,591.06 Cr for Q1 FY27 (ended June 30, 2026), up 29.1% YoY from ₹5,104.16 Cr in Q1 FY26. Consolidated profit after tax surged 77.8% YoY to ₹467.45 Cr from ₹262.91 Cr. However, the Transformer and Speciality Oils segment saw a sharp sequential decline in profit (from ₹81.87 Cr in Q4 FY26 to ₹331.34 Cr in Q1 FY27, though this is a large sequential increase, not a decline; the segment profit was ₹97.78 Cr in Q1 FY26, so YoY growth is strong). The Power/Telecom Cables segment profit fell 37.1% YoY to ₹83.07 Cr from ₹132.09 Cr, and the Conductors segment profit grew only 16.2% YoY to ₹274.40 Cr, lagging revenue growth. The company also approved incorporation of a wholly owned subsidiary in the UK and further investment of up to BRL 3,000,000 in its Brazil subsidiary.

• · Consolidated total comprehensive income for Q1 FY27 was ₹328.89 Cr, up 21.8% from ₹270.04 Cr in Q1 FY26.
• · Standalone revenue from operations for Q1 FY27 was ₹6,477.35 Cr, up 32.7% from ₹4,881.09 Cr in Q1 FY26.
• · Standalone profit after tax for Q1 FY27 was ₹453.05 Cr, up 75.7% from ₹257.86 Cr in Q1 FY26.
• · Consolidated basic EPS for Q1 FY27 was ₹116.37, up from ₹65.45 in Q1 FY26.
• · The company infused USD 50,00,000 in Apar USA LLC and ₹10.75 Cr in Cleanmax Rudra associate during the quarter.
• · Exceptional items in the previous year included a provision of ₹32.53 Cr (consolidated) for past service cost on gratuity and compensated absences.
• · The Board approved incorporation of a wholly owned subsidiary in the United Kingdom.
• · The Board approved further investment of up to BRL 3,000,000 in Apar Industries Latam Ltda, Brazil.

24-07-2026

Dr. Lal PathLabs Ltd. reported consolidated revenue of ₹7,977 million for Q1 FY27 (June 2026), up 19.1% YoY from ₹6,698 million, and net profit of ₹1,705 million, up 27.2% YoY from ₹1,340 million. However, the preceding quarter (Q4 FY26) showed a sequential revenue decline of 11.9% from ₹7,027 million, though profit rose 29.0% sequentially. The Board approved an interim dividend of ₹5 per share and noted two subsidiary-level acquisitions: an 80% stake in Sunshine Healthcare Limited (Ghana) and a stake in Neuome Technologies Private Limited (India).

• · Total expenses for Q1 FY27 were ₹6,009 million, up 16.3% YoY from ₹5,168 million.
• · Other income for Q1 FY27 was ₹319 million, up 13.5% YoY from ₹281 million.
• · Finance costs for Q1 FY27 were ₹63 million, up 34.0% YoY from ₹47 million.
• · Depreciation and amortisation expense for Q1 FY27 was ₹444 million, up 28.3% YoY from ₹346 million.
• · Fees to collection centers/channel partners for Q1 FY27 were ₹1,158 million, up 20.9% YoY from ₹958 million.
• · The record date for the interim dividend is July 30, 2026.
• · The Board of Dr. Lal PathLabs FZCO approved acquisition of 80% stake in Sunshine Healthcare Limited (Ghana) for consideration not exceeding GHS 45.60 million.
• · The Board of Dr. Lal Ventures Private Limited approved acquisition of stake in Neuome Technologies Private Limited (India).
• · During Q1 FY27, the company acquired 100% of Shahbazkers Diagnostic Centre Private Limited for ₹200 million cash, resulting in goodwill of ₹143 million.
• · A further investment of ₹77.5 million was made in Dr. Lal Ventures Private Limited during the quarter.
• · Four unaudited subsidiaries contributed total revenue of ₹76.39 million and total profit after tax of ₹8.66 million for Q1 FY27.
• · Paid-up equity share capital stood at ₹1,676 million as of June 30, 2026 (face value ₹10 per share).
• · Other equity as of March 31, 2026 (audited) was ₹23,406 million.

24-07-2026

Welspun Corp Limited's Board approved unaudited consolidated financial results for Q1 FY27 (quarter ended June 30, 2026), showing revenue of ₹4,081.12 Cr (up 14.9% YoY) and net profit of ₹1,047.88 Cr (up 200.1% YoY), boosted by a ₹547.93 Cr gain on sale of an associate stake. The Board also approved the acquisition of an additional 51% equity stake in Welspun Captive Power Generation Limited (WCPGL) from Welspun Living Limited for ₹67.66 Cr, increasing total ownership from 23% to 74%, making WCPGL a subsidiary. However, revenue declined 5.4% sequentially from ₹4,312.56 Cr in Q4 FY26, and the company reported a net loss of ₹39.78 Cr from 8 unaudited subsidiaries.

• · The Board approved an investment of ₹26,000 (26% of paid-up equity) in a new company to be incorporated in India.
• · The acquisition of WCPGL shares is subject to execution of transaction documents and statutory/regulatory approvals.
• · The unaudited consolidated results include a ₹547.93 Cr profit on sale of shares of an associate (not separately identified).
• · 8 subsidiaries (unaudited) reported total revenues of ₹46.68 Cr and a net loss of ₹39.78 Cr for the quarter.
• · 3 associates (unaudited) contributed a net profit of ₹3.09 Cr to the Group.
• · The limited review report includes a qualification regarding an overseas associate whose financials were converted from local GAAP to Ind AS.

24-07-2026

Sandeep Jain, Vikas Garg, and Rahul Nagar (Acquirers), along with PAC Neha Agarwal, have announced a mandatory open offer to acquire up to 56,43,612 equity shares (26.00%) of India Cements Capital Limited at ₹12 per share, aggregating to ₹6,77,23,344. The offer is triggered by a Share Purchase Agreement to acquire 50.02% (1,08,58,186 shares) from promoter Sri Saradha Logistics Private Limited for ₹13,02,98,232. The offer is subject to RBI approval as the target is an Authorised Dealer Category-II, and the shares are infrequently traded.

• · The target company is an Authorised Dealer Category-II registered with RBI (Certificate CHE-ADll-0001-2023), making the acquisition subject to RBI approval.
• · The equity shares of the target are infrequently traded, so the offer price was determined per Regulations 8(1) and 8(2) of SEBI (SAST) Regulations.
• · The offer is not conditional upon any minimum level of acceptance.
• · The Detailed Public Statement is to be published on or before July 31, 2026.
• · The Acquirers and PAC have confirmed adequate financial resources to meet the offer obligations.

24-07-2026

Jamna Auto Industries Ltd. has approved the acquisition of 100% of Owen Springs Limited, a UK-based manufacturer of leaf and parabolic springs, for a cash consideration of £2,000,000 (subject to net current asset adjustments). The acquisition aligns with Jamna Auto's 'Lakshya – RISE 5000' strategy to expand into new markets and strengthen its international presence. However, Owen Springs' revenue has declined over the past three years, from £3,854 thousand in 2023 to £2,760 thousand in 2025, and its PAT for CY2025 was only £132 thousand, indicating a small, underperforming target.

• · Acquisition expected to be completed by August 31, 2026.
• · Owen Springs was incorporated on July 28, 2004.
• · The acquisition is not a related party transaction.
• · No governmental or regulatory approvals are required for the acquisition.
• · Owen Springs' net worth as of December 31, 2025 was £1,041 thousand.

24-07-2026

ACC Limited reported standalone revenue from operations of ₹5,748 Crore for Q2 FY26 (quarter ended June 30, 2026), down 9.8% YoY from ₹6,256 Crore in Q2 FY25, and profit after tax fell 61.6% YoY to ₹148 Crore from ₹385 Crore. The Board also approved the acquisition of a 26% stake in Amplus Andhra Power Private Limited for approximately ₹53.1 Mn (cash consideration) to offtake electricity as a captive user. While total expenses decreased 3.4% YoY, the company booked a ₹24 Crore exceptional charge for a voluntary severance scheme, and the prior-year quarter had no such charge.

• · Standalone revenue from operations for the preceding quarter (ended March 31, 2026) was ₹7,054 Crore, indicating a sequential decline of 18.5% to ₹5,748 Crore in the current quarter.
• · Other income fell 14.5% YoY to ₹59 Crore from ₹69 Crore.
• · Finance costs decreased 10% YoY to ₹27 Crore from ₹30 Crore.
• · The company recognized a receivable/credit of ₹93 Crore as of June 30, 2026 related to Infrastructure Development Cess and Environment Cess in Chhattisgarh, following a favorable High Court judgment.
• · During the previous year ended March 31, 2026, the company reversed ₹594 Crore of tax provisions based on favorable High Court decisions and received tax refunds of ₹205 Crore.
• · The amalgamation scheme with Ambuja Cements Limited received no-objection certificates from BSE and NSE on June 4, 2026, and a joint company application has been filed with NCLT.
• · Amplus Andhra Power Private Limited's total revenue declined from ₹99.40 Mn in FY23 to ₹85.40 Mn in FY25.

24-07-2026

Perceptive Capital Solutions Corp (PCSC) completed its business combination with Freenome, Inc. on July 23, 2026, with Freenome as the accounting acquirer. The combined entity, renamed Freenome, Inc., issued 107.4 million pro forma common shares, with Freenome equity holders owning 63.4%. The transaction included a $240 million PIPE investment and conversion of a Roche convertible note. Pro forma cash and cash equivalents total $332.6 million, but the combined company has an accumulated deficit of $1.45 billion.

• · Freenome equity holders hold 63.4% of pro forma common stock; PCSC public stockholders 6.0%; sponsor shares 2.3%; PIPE investors 22.3%; Roche convertible note 6.0%.
• · Pro forma total assets: $722.6 million; total liabilities: $335.3 million.
• · Freenome historical accumulated deficit as of March 31, 2026 was $1.41 billion; pro forma accumulated deficit is $1.45 billion.
• · PCSC had $92.7 million in trust account before redemptions; $8.2 million redeemed for extension and $15.1 million at closing.
• · Freenome had $102.1 million in short-term marketable securities and $156.9 million in property and equipment as of March 31, 2026.

24-07-2026

LivePerson Inc. announced that on July 20, 2026, it received the final foreign investment clearance from the relevant Bulgarian authority for its pending acquisition by SoundHound AI, Inc., satisfying all regulatory approval conditions for the merger. The transaction, structured as a two-step merger under an Amended and Restated Merger Agreement dated July 2, 2026, remains subject to other closing conditions, including LivePerson stockholder approval. While the receipt of all required foreign investment clearances (from Italy, Canada, Germany, the UK, and now Bulgaria) is a positive milestone, the deal still faces the risk of not obtaining stockholder approval or other conditions, and the filing does not provide any financial metrics or performance data.

• · The merger is structured as a two-step process: First Merger (Merger Sub I merges into LivePerson) and Second Merger (Merger Sub II merges into LivePerson), with LivePerson surviving as an indirect wholly owned subsidiary of SoundHound.
• · Foreign investment approvals were received from Italy and Canada on June 25, 2026, Germany on June 29, 2026, the UK on July 1, 2026, and Bulgaria on July 20, 2026.
• · The filing does not disclose any financial terms of the merger, such as purchase price or valuation.
• · No financial results, revenue, profit, or operational metrics are provided in this filing.

24-07-2026

Dollar Industries Limited held a meeting of equity shareholders and unsecured creditors on July 22, 2026, to vote on a Composite Scheme of Arrangement involving the merger of nine transferor companies into Dollar Industries. The resolution was passed with 97.76% of votes in favor, representing 74.12% of total shares polled. However, public non-institutional shareholders showed significant dissent, with 2.22% voting against the scheme.

• · The meeting was held via Video Conferencing / Other Audio Visual Means (VC/OAVM) as per NCLT order.
• · Remote e-voting was open from July 19 to July 21, 2026.
• · Cut-off date for determining eligible shareholders was July 15, 2026.
• · Notice of the meeting was sent via email on June 18, 2026, and by courier to shareholders without registered email.
• · The scheme involves nine transferor companies merging into Dollar Industries Limited.
• · No invalid votes were recorded.
• · The resolution required a special majority (3/4th) and was declared passed.

24-07-2026

Sumeet Industries Limited has informed the stock exchanges that its Board of Directors will meet on July 29, 2026 to consider the issuance of equity shares upon conversion of Optionally Convertible / Redeemable Preference Shares (OCRPs) via preferential allotment, and to approve the use of Rs. 49.90 Cr from the rights issue proceeds for general corporate purposes, specifically the operationalization and integration of a CP Plant acquired from Nakoda Limited (Under Liquidation). The filing does not provide any financial performance data, so no period-over-period comparisons are available.

• · Board meeting scheduled for July 29, 2026 at 4:00 PM at the registered office in Surat, via physical or audio/video mode.
• · The meeting will consider issuance of equity shares on conversion of OCRPs by way of preferential allotment, subject to shareholder and other approvals.
• · The Rs. 49.90 Cr from the rights issue is earmarked for general corporate purpose to operationalize and integrate the CP Plant acquired from Nakoda Limited (Under Liquidation).

24-07-2026

Timken India Limited has received an order from the National Company Law Tribunal (NCLT) accepting the first motion application for the scheme of amalgamation of its wholly owned subsidiary, Timken GGB Technology Private Limited, with the company. The company is now proceeding to submit the second motion application to the NCLT. No financial figures or performance metrics were disclosed in this filing.

• · The first motion application for the amalgamation was accepted by NCLT on or before July 24, 2026.
• · The company had previously communicated about the amalgamation on May 18, 2026.
• · The order is available on the company's investor relations website.

24-07-2026

SKIL Infrastructure Ltd, currently under Corporate Insolvency Resolution Process (CIRP) per NCLT Mumbai order dated 1st February 2024, held its 8th Committee of Creditors (CoC) meeting on July 24, 2026 via virtual mode. The meeting was rescheduled from 12:15 PM to 3:00 PM and concluded at 4:15 PM. No financial results, resolution plan updates, or operational metrics were disclosed in this filing.

• · Company is under CIRP per NCLT Mumbai order dated 1st February 2024
• · Resolution Professional Purusottam Behera holds IBBI Registration No. IBBI/IPA-002/IP-N00940/2019-20/12993 (AFA valid till 31st December 2026)
• · Meeting was originally scheduled at 12:15 PM but rescheduled to 3:00 PM, concluding at 4:15 PM

24-07-2026

Standard Glass Lining Technology Limited (now Standard Engineering Technology Limited) completed Phase I of a strategic investment in GL HAKKO Co., Ltd., Japan, acquiring 19.19% stake. Phase II contemplates an additional up to 31.88% within three years, potentially increasing total stake to 51.07%, subject to regulatory approvals.

• · Phase I investment completed via remittance through prescribed banking channels.
• · Share Subscription Agreement and Shareholders' Agreement executed.
• · Phase II subject to FEFTA approval and other conditions.
• · Company name changed to Standard Engineering Technology Limited.

24-07-2026

Ekam Leasing & Finance Co. Ltd. held a meeting of equity shareholders on July 24, 2026, convened by order of the NCLT New Delhi Bench-III, to consider a Scheme of Amalgamation of Rex Overseas Private Limited and S & S Balajee Mercantile Private Limited into the company. The meeting was conducted via video conferencing, with 85 shareholders attending (including promoters), and the quorum was initially lacking but achieved after a 30-minute adjournment. The voting results and scrutinizer's report are pending separate disclosure.

• · The meeting was held pursuant to NCLT New Delhi Bench-III order dated May 08, 2026.
• · Remote e-voting was open from July 20, 2026 (09:00 AM) to July 23, 2026 (05:00 PM) via NSDL.
• · The meeting started at 4:00 PM IST and concluded at 5:35 PM IST.
• · The special resolution seeks approval for the amalgamation under Sections 230 & 232 of the Companies Act, 2013.
• · The scrutinizer's report and combined voting results will be submitted separately.

24-07-2026

Clean Max Enviro Energy Solutions Ltd's board approved the sale of 26% stakes in two wholly owned subsidiaries (Clean Max Sau and Clean Max Ni) to Fortis Hospotel Ltd and Sterling Biotech Ltd respectively for INR 26,000 each, and the acquisition of a 26% stake in Clean Max Uno Pvt Ltd from Alicon Castalloy Ltd for INR 1,25,39,936 (INR 722 per share). Post-acquisition, Clean Max Uno will become a wholly owned subsidiary. The subsidiaries have no current turnover or revenue, and the transactions are at arm's length.

• · Clean Max Sau was incorporated on 02 June 2026 and Clean Max Ni on 11 April 2026; neither contributed to turnover or revenue in the last financial year.
• · Clean Max Uno was incorporated on 06 April 2023 and had turnover of INR 0 in FY '26 and FY '25.
• · The sale agreements for Clean Max Sau and Clean Max Ni are expected to be completed by 31 August 2026 and 30 September 2026 respectively.
• · The acquisition of Clean Max Uno shares is expected to be completed by 31 August 2026.
• · None of the buyers belong to the promoter/promoter group/group companies.

24-07-2026

Share India Securities Limited's Board approved Q1 FY27 unaudited results, declared a first interim dividend of ₹0.50 per share (face value ₹2), and authorized raising up to ₹200 Crore via debt securities. The Board also approved the 100% acquisition of Enshrine Leasing and Infotech Private Limited for up to ₹45 Crore in cash, a company holding an IT Zone property in Mumbai. While the acquisition strengthens infrastructure and provides strategic control, the target's turnover has grown modestly from ₹213 Lakh (FY24) to ₹299.34 Lakh (FY26), and its net worth stands at ₹317.47 Lakh, indicating a relatively small scale.

• · Record date for interim dividend: July 30, 2026; payment before August 22, 2026.
• · Board meeting started at 06:25 PM and ended at 07:37 PM.
• · Target company incorporated on December 9, 2004, classified under software consultancy and IT-enabled services.
• · Acquisition expected to complete within 6 months from July 24, 2026.
• · No specific governmental/regulatory approval required; transaction to comply with Companies Act, 2013.

24-07-2026

NYSE Arca filed a Form 25-NSE to delist the QRAFT AI-Enhanced US Large Cap ETF (a series of Exchange Listed Funds Trust) from the exchange, effective August 4, 2026. The delisting follows a suspension of trading on July 22, 2026, and is based on the fact that the fund's securities were converted into the right to receive an immediate cash payment, effectively terminating the ETF. This represents a complete liquidation of the fund, with no ongoing trading or investment exposure.

• · The delisting is effective at the opening of business on August 4, 2026.
• · Trading in the security was suspended on July 22, 2026.
• · The delisting is pursuant to 17 CFR 240.12d2-2(a)(3), meaning the securities were converted into the right to receive an immediate cash payment.
• · The filing was made by NYSE Arca, Inc. on behalf of the issuer Exchange Listed Funds Trust.
• · The SEC file number for the issuer is 001-35977.

24-07-2026

HSBC Holdings PLC has filed a Form 25-NSE with the SEC, notifying the delisting of its 1.750% Fixed Rate/Floating Rate Senior Unsecured Notes due 2027 from the New York Stock Exchange. The delisting is effective August 4, 2026, following the redemption, maturity, or retirement of the entire class of these securities on July 24, 2026, with funds sufficient for payment deposited and made available to holders. Trading in the notes was suspended on July 24, 2026.

• · The delisting is pursuant to SEC Rule 12d2-2(a)(1).
• · The effective date of delisting is August 4, 2026.
• · The security was suspended from trading on July 24, 2026.

24-07-2026

KKR FS Income Trust Select filed a final amendment to its tender offer statement, reporting that 1,392,807.867 shares were validly tendered and accepted for purchase at a net asset value of $24.84 per share as of June 30, 2026. The aggregate purchase price was $34,563,575.18, representing approximately 3% of total shares outstanding as of March 31, 2026. The offer expired on June 29, 2026, and the company accepted 100% of the tendered shares.

• · The offer expired at 11:59 p.m. Eastern Time on June 29, 2026.
• · The company accepted 100% of the validly tendered shares, which was less than the maximum 2,030,181 shares sought.
• · The purchase price was based on the net asset value per share as of June 30, 2026, less any applicable early repurchase deduction.
• · The filing is a final amendment reporting the results of the tender offer.

24-07-2026

KKR FS Income Trust filed a final amendment to its tender offer statement, reporting that 930,353.321 shares were validly tendered and accepted for purchase at a net asset value of $29.07 per share as of June 30, 2026. The aggregate purchase price was $27,028,354.70, representing approximately 2% of total shares outstanding as of March 31, 2026. The offer expired on June 29, 2026, and all validly tendered shares were accepted.

• · The tender offer expired at 11:59 p.m. Eastern Time on June 29, 2026.
• · The company accepted 100% of the validly tendered shares, which was less than the maximum 2,819,258 shares offered to purchase.
• · The net asset value per share was determined on July 20, 2026, as of June 30, 2026.
• · The purchase price reflects the net asset value less any applicable early repurchase deduction.

24-07-2026

Kitex Garments Limited held NCLT-convened meetings of equity shareholders and unsecured creditors on July 24, 2026, to consider and approve a Scheme of Arrangement with Kitex Childrenswear Limited under Sections 230-232 of the Companies Act, 2013. Both meetings were conducted via video conference and concluded with the requisite majority approval, though no specific vote counts or financial details of the scheme were disclosed in this filing.

• · Equity shareholders meeting held at 11:00 AM IST on July 24, 2026, concluded at 11:44 AM IST.
• · Unsecured creditors meeting held at 2:30 PM IST on July 24, 2026, concluded at 3:04 PM IST.
• · Remote e-voting period: July 20, 2026 (9:00 AM IST) to July 23, 2026 (5:00 PM IST).
• · No shareholders or unsecured creditors registered to ask questions; Q&A session dispensed with.
• · The filing does not disclose the voting results, the number of votes cast, or the specific terms of the Scheme of Arrangement.

24-07-2026

VivoSim Labs received a Nasdaq delisting notice on July 20, 2026, for failing to meet the minimum $2.5M stockholders' equity requirement under Listing Rule 5550(b)(1), as its Annual Report showed negative equity of $(1,099,000). However, subsequent transactions—including a $5.0M milestone payment from Eli Lilly, a $4.0M private placement, and the exercise of warrants adding ~$5.1M to equity—have brought stockholders' equity back above $2.5M as of the filing date. The company has until September 3, 2026 to submit a compliance plan, and its stock remains listed on Nasdaq under 'VIVS' for now.

• · The company has 45 calendar days from July 20, 2026 (until September 3, 2026) to submit a compliance plan to Nasdaq.
• · If Nasdaq accepts the plan, it may grant an extension of up to 180 calendar days (until January 16, 2027) to regain compliance.
• · If the plan is not accepted, the company has the right to appeal to a Nasdaq hearings panel.
• · The private placement closed on July 17, 2026, with a combined purchase price of $0.85 per share/pre-funded warrant and accompanying common warrant.
• · The company's common stock continues to trade on the Nasdaq Capital Market under symbol 'VIVS' with no immediate effect on listing.

24-07-2026

FibroBiologics, Inc. received a Staff Determination letter from Nasdaq on July 22, 2026, notifying the company that its securities will be delisted from The Nasdaq Capital Market due to non-compliance with the minimum bid price rule (closing bid price below $1.00 per share for 30 consecutive business days). The company is not eligible for the standard 180-day compliance period because it effected a reverse stock split within the prior year. FibroBiologics intends to appeal the determination by requesting a hearing before a Nasdaq Hearings Panel, which will stay the delisting pending the hearing process, but there is no assurance of success.

• · The delisting determination was based on the bid price closing below $1.00 per share from June 8, 2026 through July 21, 2026.
• · The company must request an appeal by July 29, 2026 to stay the delisting; otherwise, suspension will begin at the opening of business on July 31, 2026.
• · The company is ineligible for the 180-day compliance period due to a reverse stock split effected within the prior one-year period.

24-07-2026

Invivyd, Inc. received a Nasdaq deficiency letter on July 23, 2026, because its common stock (IVVD) closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until January 19, 2027 to regain compliance, with a potential second compliance period if it transfers to the Nasdaq Capital Market. There is no assurance that Invivyd will be able to cure the deficiency, and failure could lead to delisting.

• · The deficiency letter was received on July 23, 2026, and the filing was made on July 24, 2026.
• · The company's common stock has a par value of $0.0001 per share.
• · The initial compliance period ends on January 19, 2027.
• · If the company does not regain compliance by that date, it may be eligible for a second 180-day compliance period by transferring to the Nasdaq Capital Market.
• · The company intends to monitor the bid price and consider options, but there is no assurance of regaining compliance.

24-07-2026

Trinity Capital Inc. has voluntarily filed a Form 25 with the SEC to delist its common stock and two series of 7.875% Notes (due March 2029 and September 2029) from The Nasdaq Stock Market, effective July 24, 2026. The delisting is a voluntary withdrawal by the issuer and not a result of regulatory or exchange action. This move will reduce liquidity and market access for existing shareholders and noteholders.

• · The delisting covers all three classes of securities: common stock and two series of notes.
• · The filing cites 17 CFR 240.12d2-2(c) for voluntary withdrawal, not a forced delisting.
• · No financial details or reasons for the delisting are provided in the filing.

24-07-2026

Isabella Bank Corp (ISBA) filed an S-4 registration statement on July 24, 2026, in connection with its proposed merger with Grand River Commerce, Inc. The filing includes a proxy statement/prospectus for a special meeting of Grand River shareholders to vote on the merger proposal and an adjournment proposal. The Grand River board recommends voting 'FOR' both proposals, and directors and executive officers have entered into voting agreements to vote their shares in favor of the merger.

• · The special meeting will be held via Zoom video conference with no in-person attendees.
• · Approval of the Grand River merger proposal requires the affirmative vote of holders of at least a majority of outstanding shares of voting Grand River common stock.
• · Abstentions and failures to vote will be counted as votes 'against' the Grand River merger proposal.
• · Grand River directors and executive officers have entered into voting agreements with Isabella to vote all their shares in favor of the merger.
• · Grand River has retained Regan & Associates, Inc. as proxy solicitor, with fees to be determined.
• · Isabella and Grand River will share equally the expenses of printing and mailing the proxy statement/prospectus.

24-07-2026

AMR Resources Acquisition Corp. completed its IPO on July 20, 2026, selling 26,000,000 units at $10.00 each for gross proceeds of $260,000,000, including partial exercise of the underwriters' over-allotment option. Simultaneously, the company raised an additional $7,075,000 through a private placement of 707,500 units to the sponsor and underwriters. The net proceeds are held in a trust account to fund a future business combination, with the company focusing on targets in the mineral resources sector but not yet having identified any specific target.

• · The company is a blank check company (SPAC) incorporated in the Cayman Islands on December 16, 2025.
• · The company has not yet selected any specific business combination target and has not engaged in any substantive discussions with any target.
• · The company intends to focus on target businesses in the mineral resources sector but may pursue opportunities in any industry.
• · As of July 20, 2026, the company had not commenced any operations and will not generate operating revenues until after a business combination.
• · The company has an accumulated deficit of $8,220,611 and a total shareholders' deficit of $8,219,581.
• · Transaction costs totaled $15,008,723, including $5,200,000 in cash underwriting fees, $9,100,000 in deferred underwriting fees, and $708,723 in other offering costs.
• · The trust account holds $260,000,000 ($10.00 per unit) from the IPO proceeds.
• · The underwriters partially exercised their over-allotment option for 1,000,000 units; 2,750,000 units remain unexercised.
• · As a result of the partial over-allotment exercise, 333,333 founder shares are no longer subject to surrender, and 916,667 founder shares remain subject to surrender.
• · The company's Class A ordinary shares, warrants, and units are listed on The Nasdaq Stock Market LLC under symbols AMAC, AMACW, and AMACU, respectively.

24-07-2026

Carlyle Credit Solutions, Inc. filed Amendment No. 1 to its Schedule TO, announcing the final results of its issuer tender offer that expired on July 20, 2026. The company accepted for purchase 3,406,190 shares of its common stock at a price equal to the net asset value per share as of June 30, 2026, representing approximately 3.567% of total shares outstanding. The offer was for up to 4,878,153 shares, meaning the company purchased approximately 69.8% of the maximum shares sought, indicating a lower-than-maximum participation rate.

• · The tender offer expired at 11:59 p.m., New York City Time, on July 20, 2026.
• · The purchase price per share was equal to the net asset value per share as of June 30, 2026.
• · The company accepted 3,406,190 shares out of a maximum of 4,878,153 shares sought, representing a 69.8% uptake rate.
• · The accepted shares represent approximately 3.567% of total shares outstanding as of June 30, 2026.
• · The filing is an amendment (Amendment No. 1) to the initial Schedule TO filed on June 22, 2026.
• · The company issued a letter to stockholders on July 24, 2026 announcing the final results.

24-07-2026

Berkshire Hathaway completed its acquisition of Taylor Morrison Home Corp for $72.50 per share in cash, representing a total equity value of approximately $6.8 billion and total enterprise value of approximately $8.5 billion. Taylor Morrison will be integrated with Berkshire's site-built homebuilding operations (Clayton Properties Group) and will continue to be led by CEO Sheryl Palmer. The combined entity delivered nearly 23,000 home closings in 2025, operates in 21 states and 52 housing markets, and is positioned as the fourth largest homebuilding operation in the U.S.

• · Taylor Morrison has been recognized as America's Most Trusted Builder by Lifestory Research since 2016.
• · Taylor Morrison was honored as one of Fortune's World's Most Admired Companies in 2026.
• · The combined entity serves renters, entry-level, move-up, and resort lifestyle segments.

24-07-2026

Acura Pharmaceuticals, Inc. filed an 8-K to disclose an amended loan schedule under a Secured Promissory Note originally dated November 10, 2022 with Abuse Deterrent Pharma, LLC. The amendment adds 63 additional loans totaling $10,894,279 in aggregate principal, including $2,319,279 from the original note and $7,075,000 from prior loans (Loans #1 through #50) plus $1,500,000 in new loans (Loans #51 through #63) advanced between January and July 2026. The filing reflects ongoing debt financing but does not indicate a merger or acquisition.

• · The amended loan schedule includes 63 loans in total, with the original note dated November 10, 2022.
• · New loans (Loans #51 through #63) were advanced in 2026, with individual amounts of $100,000 or $200,000 each.
• · The filing is dated July 24, 2026, but the amendment was signed on July 20, 2026.

24-07-2026

Blue Owl Credit Income Corp. completed a tender offer to repurchase up to 5.00% of its outstanding shares as of March 31, 2026, but received tenders for 18.8% of shares, indicating strong shareholder demand. The company accepted approximately 26.6% of validly tendered shares on a pro rata basis, repurchasing about 105.2 million shares for a total of approximately $955 million. Payment was made via non-interest bearing promissory notes held by the transfer agent.

• · The tender offer expired on June 30, 2026 at 7:00 PM Eastern Time.
• · Net offering prices per share as of June 30, 2026: Class S $9.05, Class D $9.06, Class I $9.08.
• · Payment was made via non-interest bearing promissory notes held by DST Systems Inc., the transfer agent.
• · The filing is a final amendment (Amendment No. 1) reporting the results of the tender offer.

24-07-2026

Chegg, Inc. received a NYSE notice on July 24, 2026 for non-compliance with the minimum share price requirement (average closing price below $1.00 over 30 consecutive trading days). This is the second such notice, following a prior notice in December 2025 that was cured by end of May 2026. The company has a six-month cure period and may consider a reverse stock split, but faces potential delisting if it fails to regain compliance.

• · The prior NYSE notice from December 2025 was cured by end of May 2026, but the company has now fallen out of compliance again.
• · The company can regain compliance if on the last trading day of any calendar month during the six-month cure period the closing price is at least $1.00 and the 30-trading-day average is at least $1.00.
• · The notice has no immediate impact on listing; shares continue to trade on NYSE during the cure period.

24-07-2026

Renatus Tactical Acquisition Corp I appointed Lauren Selig as a director effective July 21, 2026, and to its Audit, Compensation, and Nominating and Corporate Governance Committees. Ms. Selig brings over 25 years of experience in entertainment, technology, AI, blockchain, and venture investments. She will not receive cash compensation but will be issued 50,000 Class B ordinary shares by the sponsor as compensation.

• · Ms. Selig was appointed to the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.
• · She has entered into an indemnity agreement and a letter agreement on the same terms as those entered into by directors and officers at the time of the IPO.
• · Ms. Selig has agreed to vote any Class A Ordinary Shares held by her in favor of the Company's initial business combination and to facilitate liquidation if a business combination is not consummated within 24 months (or up to 30 months by Board resolution).
• · There are no family relationships between Ms. Selig and any other director or executive officer, and she was not selected pursuant to any arrangement with any person.
• · Ms. Selig has not engaged in any related party transaction reportable under Item 404(a) of Regulation S-K.

24-07-2026

Blue Owl Technology Income Corp. completed a tender offer to repurchase up to 5.00% of its outstanding shares as of March 31, 2026. The offer expired on June 30, 2026, with 109,888,749 shares validly tendered (38.1% of outstanding shares), but only 14,438,906 shares were accepted on a pro-rata basis (13.1% of tendered shares) for a total aggregate purchase price of approximately $140,057,390. Payment was made via non-interest bearing promissory notes, and no Class D shares were tendered or repurchased.

• · The offer was made under Rule 13e-4 (issuer tender offer) and this filing is a final amendment reporting the results.
• · All share classes (S, D, I) had the same net offering price per share of $9.70 as of June 30, 2026.
• · No Class D shares were tendered in the offer.
• · Payment was made via non-interest bearing promissory notes held by the transfer agent, not cash.
• · The offer expiration date was June 30, 2026 at 7:00 PM Eastern Time.

24-07-2026

GoPro, Inc. received a notice from Nasdaq on July 21, 2026, stating that its Class A common stock has failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days, violating Listing Rule 5450(a)(1). The company has a 180-calendar-day grace period to regain compliance by achieving a closing bid price of at least $1.00 for ten consecutive business days. The notice does not immediately affect the listing or trading of GPRO shares on the Nasdaq Global Select Market.

• · The minimum bid price threshold is $1.00 per share.
• · The company must maintain a closing bid price of $1.00 or more for at least ten consecutive business days during the 180-day period to regain compliance.
• · The notice was received on July 21, 2026, and the 8-K was filed on July 24, 2026.
• · The company's Class A common stock trades under the symbol GPRO on the Nasdaq Global Select Market.

24-07-2026

D-Wave Quantum Inc. (QBTS) has voluntarily filed Form 25 with the SEC to withdraw its common stock from listing and registration on the New York Stock Exchange (NYSE), effective July 24, 2026. The delisting is a voluntary action certified by the company under SEC Rule 12d2-2(c), and was signed by President & CEO Alan Baratz. This represents a significant corporate event that will remove the company's shares from public trading on a major U.S. exchange.

• · The delisting is voluntary under SEC Rule 12d2-2(c), not an involuntary removal by the exchange.
• · The company's principal executive offices are located at 2650 East Bayshore Road, Palo Alto, California 94303.
• · The class of securities affected is common stock with a par value of $0.0001 per share.
• · The filing was made on July 24, 2026, and the delisting is effective as of that date.

24-07-2026

Standard BioTools Inc. (LAB) received a Nasdaq notice on July 22, 2026, for failing to meet the $1.00 minimum bid price requirement over 30 consecutive business days. The company has a 180-day compliance period until January 19, 2027, to regain compliance, and its stock continues to trade uninterrupted. While the company intends to work toward restoring compliance, there is no assurance it will succeed, and a potential transfer to the Nasdaq Capital Market or a reverse stock split may be necessary.

• · The company has 180 calendar days, until January 19, 2027, to regain compliance with the minimum bid price requirement.
• · To regain compliance, the closing bid price must be at least $1.00 for a minimum of 10 consecutive business days.
• · If the company meets all other continued listing standards, it may be eligible for an additional 180-day compliance period by transferring to the Nasdaq Capital Market.
• · The company may need to implement a reverse stock split to cure the deficiency.
• · The notice has no immediate effect on trading or business operations.

24-07-2026

Arrive AI Inc. received a Nasdaq notification on July 21, 2026, for failing to meet the minimum Market Value of Publicly Held Shares (MVPHS) requirement of $15 million for 32 consecutive business days. The stock continues to trade under 'ARAI' with no immediate effect, but the company has 180 days (until January 19, 2027) to regain compliance or face potential delisting. While the company intends to monitor and pursue compliance options, the notification highlights ongoing market value weakness.

• · Non-compliance was specifically with Nasdaq Listing Rule 5450(b)(2)(C) for minimum MVPHS of $15 million.
• · The non-compliance period ran from June 3, 2026 to July 20, 2026 (32 consecutive business days).
• · The cure period ends on January 19, 2027; if not met, Nasdaq will issue a delisting notification.
• · An alternative option is applying for a transfer to The Nasdaq Capital Market, subject to meeting continued listing requirements.
• · The company's common stock par value is $0.0002 per share.

24-07-2026

Range Capital Acquisition Corp. disclosed a $60,000 drawdown on July 23, 2026, from its unsecured promissory note with its sponsor, bringing the total outstanding to $120,000. The funds were deposited into the trust account to support the company's ongoing search for an initial business combination. The note, which allows for up to $540,000 in total draws, is non-interest bearing and repayable upon consummation of a business combination or winding up.

• · The note was originally issued on June 18, 2026, as previously reported in an 8-K filed June 25, 2026.
• · The note is unsecured, non-interest bearing, and repayable only from amounts outside the trust account if no business combination is consummated.
• · The issuance was made under the Section 4(a)(2) exemption from registration.

24-07-2026

Odyssey Marine Exploration received a Nasdaq deficiency notice on July 21, 2026, for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days, violating Listing Rule 5550(a)(2). The company has a 180-day cure period ending January 19, 2027, and plans to regain compliance via a reverse stock split (1-for-20 to 1-for-25) approved by stockholders on June 1, 2026, ahead of its merger with American Ocean Minerals Corporation. While the notice has no immediate delisting impact, failure to cure could lead to delisting, and the company's stock price remains below $1.00, reflecting ongoing financial distress.

• · Stockholders approved a reverse stock split on June 1, 2026, at a ratio between 1-for-20 and 1-for-25.
• · The company expects the reverse stock split to enable compliance before the merger with AOM closes.
• · If not compliant by January 19, 2027, the company may qualify for an additional 180-day period if it meets other listing standards.
• · The merger with AOM was previously disclosed on April 8, 2026.

24-07-2026

Oncolytics Biotech Inc. received a Nasdaq deficiency letter on July 20, 2026, for failing to maintain a minimum bid price of $1.00 per share over 30 consecutive business days, triggering potential delisting. The company has a 180-day compliance period (until January 19, 2027) to regain compliance, and may qualify for an additional 180-day extension if certain conditions are met. The company is assessing options, but there is no assurance it will regain compliance or avoid delisting.

• · Letter received on July 20, 2026, from Nasdaq Listing Qualifications Staff.
• · Stock trades under symbol 'ONCY' on the Nasdaq Capital Market.
• · If compliance is regained during the Compliance Period, Nasdaq will confirm in writing.
• · For an additional 180-day period, the company must meet the market value of publicly held shares requirement and all other initial listing standards except the minimum bid price.
• · If the company is not eligible or cannot cure the deficiency, the stock will be subject to delisting.

24-07-2026

Liminatus Pharma, Inc. disclosed it has not regained compliance with Nasdaq's minimum bid price rule ($1.00) and is not eligible for a second 180-day extension. The Nasdaq Hearings Panel will decide on continued listing, with the company required to submit its views by July 27, 2026. The company is also seeking shareholder approval for a reverse stock split at its August 3, 2026 annual meeting as a potential remedy.

• · The company received the initial non-compliance notice on January 15, 2026, and the 180-day compliance period ended July 14, 2026.
• · A hearing before the Nasdaq Hearings Panel was held on June 30, 2026.
• · The company must submit its written response to the Panel regarding the additional deficiency by July 27, 2026.
• · The annual meeting of stockholders is scheduled for August 3, 2026, to authorize a reverse stock split.

24-07-2026

QVC Inc. and its parent QVC Group Inc. received court confirmation of their prepackaged Chapter 11 plan of reorganization on July 20, 2026. Under the plan, existing equity interests (common and preferred stock) will be canceled for no consideration, while secured noteholders will receive a pro rata share of new equity, cash, and takeback debt. Trade and other unsecured claims will be paid in full or reinstated, and the company expects to emerge from bankruptcy after satisfying conditions precedent.

• · The Chapter 11 cases are jointly administered under case No. 26-90447 (ARP) in the Southern District of Texas.
• · The Confirmation Order was entered on July 20, 2026 (Docket No. 722).
• · Holders of Allowed RCF Claims and Allowed QVC Notes Claims will receive pro rata share of QVC Funded Debt Plan Consideration (cash, takeback debt, and 100% of new equity, subject to MIP dilution).
• · Holders of Allowed LINTA Notes Claims will receive pro rata share of LINTA Distributable Cash.
• · All indemnification obligations for current/former directors, officers, employees, and professionals will be reinstated and survive the Effective Date.
• · The company cautions that trading in its securities during the Chapter 11 Cases is highly speculative and may bear little relation to actual recoveries.
• · The company expects that equity holders will receive no distributions and all equity interests will be canceled for no consideration.

24-07-2026

QVC Group, Inc. filed for Chapter 11 bankruptcy on April 16, 2026, and on July 20, 2026, the Bankruptcy Court confirmed its prepackaged plan of reorganization. Under the plan, all existing equity interests (common and preferred stock) will be canceled for no consideration, while secured and unsecured trade claims will be paid in full. The company expects to emerge from bankruptcy after satisfying conditions precedent, with 50 million new common shares to be issued.

• · All existing equity interests (Series A common, Series B common, and 8.0% Series A Cumulative Redeemable Preferred Stock) will be canceled for no consideration on the Effective Date.
• · Holders of Allowed RCF Claims and Allowed QVC Notes Claims will receive pro rata share of QVC Funded Debt Plan Consideration, including QVC Distributable Cash, Takeback Debt, and 100% of QVC New Equity Interests (subject to dilution by MIP Shares).
• · Holders of Allowed LINTA Notes Claims will receive their pro rata share of LINTA Distributable Cash.
• · All other secured and unsecured claims (including trade claims) will be paid in full in cash, reinstated, or otherwise rendered unimpaired.
• · Indemnification obligations for current and former directors, officers, and other professionals will be reinstated and survive the Effective Date.
• · The Chapter 11 Cases are being jointly administered under Case No. 26-90447 (ARP) in the Southern District of Texas.

24-07-2026

LiqTech International received a Nasdaq deficiency notice on July 21, 2026, for failing to maintain the $1 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until January 19, 2027, to regain compliance by having the closing bid price meet or exceed $1.00 for at least ten consecutive business days. While the stock continues to trade under the symbol "LIQT" for now, failure to cure could lead to delisting, though an additional 180-day compliance period may be available if certain conditions are met.

• · The deficiency notice was received on July 21, 2026, and the filing was made on July 24, 2026.
• · The stock continues to trade on The Nasdaq Capital Market under the symbol "LIQT" with no immediate effect on listing.
• · If the company does not qualify for or fails to cure during the second 180-day compliance period, Nasdaq will notify the company of its determination to delist, with an opportunity to appeal to a Hearings Panel.
• · The company is considering its options to regain compliance but has not specified any concrete plan.

24-07-2026

Fusemachines Inc. (FUSE) received a Nasdaq notification on July 24, 2026, for failing to maintain the minimum Market Value of Publicly Held Shares (MVPHS) of $15,000,000 for the Nasdaq Global Market, as its MVPHS was below that threshold for 30 consecutive business days from June 10 to July 23, 2026. The company has 180 calendar days, until January 20, 2027, to regain compliance by closing at or above $15,000,000 for at least 10 consecutive business days. There is no immediate impact on listing or trading, and the company intends to evaluate options to regain compliance, though the outcome remains uncertain.

• · The non-compliance period for MVPHS was from June 10, 2026 through July 23, 2026.
• · The company's common stock continues to trade under the symbol 'FUSE' on the Nasdaq Global Market during the compliance period.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.

24-07-2026

Peraso Inc. (PRSO) received a Nasdaq deficiency notice on July 21, 2026, for failing to maintain a minimum bid price of $1 per share for 30 consecutive business days. The company has a 180-day cure period until January 19, 2027, and is considering options including a potential reverse stock split. Separately, the board set the 2026 Annual Meeting for September 10, 2026, with a stockholder proposal deadline of August 3, 2026.

• · Stockholders of record as of July 20, 2026 are entitled to vote at the 2026 Annual Meeting.
• · Stockholder proposals under Rule 14a-8 must be received by August 3, 2026.
• · Director nominations and other business outside Rule 14a-8 must also be submitted by August 3, 2026.
• · Universal proxy rule compliance notices are due by August 3, 2026.

24-07-2026

Surf Air Mobility Inc. received a notice from the NYSE on July 24, 2026, indicating non-compliance with the minimum average closing price of $1.00 over 30 consecutive trading days. The company has a six-month cure period to regain compliance. At the same time, shareholders approved a reverse stock split (ratio 2:1 to 6:1) to address the listing deficiency, and ratified PwC as auditor. However, the stock remains listed with no immediate impact on operations or SEC reporting.

• · The reverse stock split ratio ranges from 2:1 to 6:1, inclusive.
• · The company has 10 business days from receipt of the notice to notify NYSE of its intent to cure.
• · The cure period is six months following receipt of the notice.
• · To regain compliance, the company must have a closing share price of at least $1.00 on the last trading day of any calendar month during the cure period and an average closing price of at least $1.00 over the prior 30 trading days.
• · The notice has no immediate effect on the listing of the common stock.